Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 3

1(33.3%)

Phase 1

1(33.3%)

N/A

1(33.3%)

3Total

Phase 3(1)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT06582810Recruiting

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches

Role: collaborator

NCT04021602Not ApplicableCompleted

Diabetes Prevention Program Feasibility Study of Breastfeeding

Role: collaborator

NCT05157360Phase 1Terminated

HAT for the Treatment of Sepsis Associated With NASTI

Role: lead

NCT00934193Phase 3Withdrawn

Does Peri-Operative Gabapentin Reduce Chronic Post-Thoracotomy Pain?

Role: collaborator

All 4 trials loaded